SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-215689
Filing Date
2022-08-09
Accepted
2022-08-09 08:31:06
Documents
14
Period of Report
2022-08-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d310015d8k.htm   iXBRL 8-K 25361
2 EX-99.1 d310015dex991.htm EX-99.1 9801
6 GRAPHIC g310015g0809085015468.jpg GRAPHIC 2084
  Complete submission text file 0001193125-22-215689.txt   160533

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20220809.xsd EX-101.SCH 2871
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20220809_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20220809_pre.xml EX-101.PRE 10822
8 EXTRACTED XBRL INSTANCE DOCUMENT d310015d8k_htm.xml XML 3225
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 221146645
SIC: 3841 Surgical & Medical Instruments & Apparatus